Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2016 16:05 ET | Source: Zogenix, Inc.

New Data on Zogenix’s ZX008 for Lennox Gastaut Syndrome & Dravet Syndrome to be Presented at 70th Annual American Epilepsy Society Meeting

Interim Results of Investigator Initiated Phase 2 study of ZX008 in Lennox Gastaut Syndrome to be PresentedUpdate from Ongoing Open-Label Prospective Study of ZX008 in Dravet Syndrome Will Also be...
November 22, 2016 08:00 ET | Source: Zogenix, Inc.

Zogenix to Participate in Oppenheimer Life Sciences Summit 2016

EMERYVILLE, Calif., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
November 08, 2016 08:00 ET | Source: Zogenix, Inc.

Zogenix to Participate in Stifel 2016 Healthcare Conference

EMERYVILLE, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
November 07, 2016 16:01 ET | Source: Zogenix, Inc.

Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results

EMERYVILLE, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
October 31, 2016 08:00 ET | Source: Zogenix, Inc.

Zogenix to Release Third Quarter 2016 Financial Results and Host Conference Call and Webcast on November 7

EMERYVILLE, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
September 20, 2016 08:00 ET | Source: Zogenix, Inc.

Zogenix to Participate in Two Upcoming Investor Conferences

EMERYVILLE, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
September 08, 2016 16:05 ET | Source: Zogenix, Inc.

Zogenix to have Significant Presence at 12th European Congress on Epileptology

EMERYVILLE, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
August 09, 2016 16:01 ET | Source: Zogenix, Inc.

Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results

EMERYVILLE, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
August 02, 2016 08:00 ET | Source: Zogenix, Inc.

Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9

EMERYVILLE, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS)...
June 21, 2016 08:00 ET | Source: Zogenix, Inc.

Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash Balance

- Interest-only repayment provision results in $10 million increase to Zogenix’s expected cash balance at the end of 2017 - EMERYVILLE, Calif., June 21, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc....

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right